Brief: Endra Life Sciences Got Letter From Nasdaq On No Longer Meeting Continued Listing Minimum Bid Price Requirement
03/05/2024 21:42
May 3 (Reuters) - ENDRA Life Sciences Inc NDRA.O :
* ENDRA LIFE SCIENCES: GOT LETTER FROM NASDAQ THAT CO NO
LONGER
MEETS MINIMUM BID PRICE REQUIREMENT FOR CONTINUED LISTING ON
NASDAQ CAPITAL MARKET
Source text for Eikon: ID:n0001654954-24-005552
Further company coverage: NDRA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on ENDRA Life Sciences
See all newsBrief: ENDRA Life Sciences - Enters First Amendment To Merger Agreement On October 1, 2026 - SEC Filing
ENDRA Life Sciences posts Q2 profit on digital asset gains ahead of merger
Endra Life Sciences Inc Reports Results For The Quarter Ended June 30: Earnings Summary
Endra Life Sciences Inc Expected To Post A Loss Of 84 Cents A Share: Earnings Preview
Brief: ASP Isotopes Announces Proposed Merger Of Noble Africa With Endra Life Sciences